The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Authors
Keywords
-
Journal
International Journal of Endocrinology
Volume 2015, Issue -, Pages 1-17
Publisher
Hindawi Limited
Online
2015-06-02
DOI
10.1155/2015/245459
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: A reciprocal risk factor for depression and insulin resistance?
- (2015) Igor A. Pomytkin et al. BEHAVIOURAL BRAIN RESEARCH
- The interaction between nutrition and the brain and its consequences for body weight gain and metabolism; studies in rodents and men
- (2014) Susanne E. la Fleur et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Dopamine signaling in food addiction: role of dopamine D2 receptors
- (2014) Ja-Hyun Baik BMB Reports
- Perifornical Hypothalamic Orexin and Serotonin Modulate the Counterregulatory Response to Hypoglycemic and Glucoprivic Stimuli
- (2014) Oleg Otlivanchik et al. DIABETES
- Modeling type 2 diabetes in rats using high fat diet and streptozotocin
- (2014) Søs Skovsø Journal of Diabetes Investigation
- The functional activity of adenylyl cyclase signaling system in the brain, myocardium, and testes of rats with 8- and 18-month neonatal diabetes
- (2013) K. V. Derkach et al. Doklady Biochemistry and Biophysics
- The Role of Bromocriptine-QR in the Management of Type 2 Diabetes Expert Panel Recommendations
- (2013) Alan Garber et al. Endocrine Practice
- Oxidative Stress in Diabetes: Implications for Vascular and Other Complications
- (2013) Dario Pitocco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis
- (2013) Eric D. Berglund et al. JOURNAL OF CLINICAL INVESTIGATION
- Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function
- (2013) Christine Saunders et al. NEUROCHEMISTRY INTERNATIONAL
- Serotonin 1A, 1B, and 7 receptors of the rat medial nucleus accumbens differentially regulate feeding, water intake, and locomotor activity
- (2013) Kara A. Clissold et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
- (2013) J. Michael Gaziano et al. Journal of the American Heart Association
- Endoplasmic Reticulum Is at the Crossroads of Autophagy, Inflammation, and Apoptosis Signaling Pathways and Participates in the Pathogenesis of Diabetes Mellitus
- (2013) Jing Su et al. Journal of Diabetes Research
- Serotonergic effects on feeding, but not hypothalamus-pituitary-adrenal secretion, are altered in ovine pregnancy
- (2012) Melissa Lingis et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Chronic fluoxetine reduces autonomic control of cardiac rhythms in rats with congestive heart failure
- (2012) Marcus Henze et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults
- (2012) Michael Deuschle CURRENT OPINION IN PSYCHIATRY
- Effect of bromocriptine on cardiovascular complications associated with metabolic syndrome in fructose fed rats
- (2012) LaxmanA Kawale et al. INDIAN JOURNAL OF PHARMACOLOGY
- Selective serotonin receptor stimulation of the medial nucleus accumbens differentially affects appetitive motivation for food on a progressive ratio schedule of reinforcement
- (2012) Wayne E. Pratt et al. NEUROSCIENCE LETTERS
- Intranasal Treatment of Central Nervous System Dysfunction in Humans
- (2012) Colin D. Chapman et al. PHARMACEUTICAL RESEARCH
- Use of antidepressant agents and the risk of type 2 diabetes
- (2011) S. Khoza et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Oxidative stress and endothelial dysfunction in hypertension
- (2011) Eberhard Schulz et al. HYPERTENSION RESEARCH
- Quick-Release Bromocriptine for Treatment of Type 2 Diabetes
- (2011) Nasser Mikhail Current Drug Delivery
- Intranasal insulin affects adenyl cyclase system in rat tissues in neonatal diabetes
- (2011) Alexander Shpakov et al. Open Life Sciences
- Encephalopathies: the emerging diabetic complications
- (2010) Anders A. F. Sima ACTA DIABETOLOGICA
- Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine
- (2010) Ulderico Freo et al. BRAIN RESEARCH
- The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
- (2010) Kenneth Cusi Current Diabetes Reports
- The Peptides Mimicking the Third Intracellular Loop of 5-Hydroxytryptamine Receptors of the Types 1B and 6 Selectively Activate G Proteins and Receptor-Specifically Inhibit Serotonin Signaling via the Adenylyl Cyclase System
- (2010) Alexander O. Shpakov et al. International Journal of Peptide Research and Therapeutics
- Association of metabolic syndrome with reduced central serotonergic activity
- (2010) Rocio Herrera-Marquez et al. METABOLIC BRAIN DISEASE
- The Expanded Biology of Serotonin
- (2009) Miles Berger et al. Annual Review of Medicine
- Selective serotonin receptor stimulation of the medial nucleus accumbens causes differential effects on food intake and locomotion.
- (2009) Wayne E. Pratt et al. BEHAVIORAL NEUROSCIENCE
- Disruption of the Circadian Timing Systems
- (2009) Julien Mendlewicz CNS DRUGS
- Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes
- (2009) Richard Scranton et al. EXPERT OPINION ON PHARMACOTHERAPY
- Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
- (2009) Rajiv Mahajan INDIAN JOURNAL OF PHARMACOLOGY
- An Association Between Stress-Induced Disruption of the Hypothalamic-Pituitary-Adrenal Axis and Disordered Glucose Metabolism in an Animal Model of Post-Traumatic Stress Disorder
- (2009) H. Cohen et al. JOURNAL OF NEUROENDOCRINOLOGY
- Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression
- (2009) S Kloiber et al. MOLECULAR PSYCHIATRY
- Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models
- (2009) Angela J. Grippo et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice
- (2008) Katsunori Nonogaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now